TY - JOUR
AU - Curtis, David R
AB - 686 COMMUNICATIONS REFERENCES dihydroxyphenylacetic acid (DOPAC), another DA metabolite, were increased up to sixfold by 5- Bartholini, G., Constantinidis, J., Puig, M., Tissot, R., hydroxytryptophan, the amino acid precursor of 5- A. (1975) J. Pharmacol. Exp. Ther. 193: hydroxytryptamine (5-HT). They suggested that this 523-532 effect might be due to the displacement Of DA by 5-HT Creveling, C, R,, Daly, J,, Tokuyama, T,, Witkop, B, formed in dopaminergic neurons. Similarly, it is pos- (1968) Biochem, pharmaco], 17: 65-70 sible that increases in DA metabolites that have been Edwards, D, J, (1982) Life sci, 30: 1427-1434 reported following tyrosine injections (Sved et a1 1979; Edwards, D, J,, Rizk, M, (1981a) Prog, Neuro- Edwards 1982) result, in part, by the indirect actions of Psychopharmacol. 5: 569-572 tyramine formed in DA neurons. Edwards, D. J., Rizk, M. (1981b) J. Neurochem. 36: In summary, we have demonstrated that DOPS Edwards, D. J., hzk, M., SPiker, D. G. (1981) Biochem. produces an increase in the brain levels of DA metabol- Med. 25: 135-148 ites. Caution should be used before any behavioral or Fu~~rs~&~~ Perry3 K. w. (1981) J. Pharmacol. pharmacological effects of DOPS are attributed solely to the function of NA neurons. Goodwin, B. 
TI - In vitro and in vivo effects of pentobarbitone sodium
JO - Journal of Pharmacy and Pharmacology
DO - 10.1111/j.2042-7158.1982.tb04707.x
DA - 1982-10-01
UR - https://www.deepdyve.com/lp/oxford-university-press/in-vitro-and-in-vivo-effects-of-pentobarbitone-sodium-u08OzHBq7y
SP - 686
EP - 686
VL - 34
IS - 10
DP - DeepDyve
ER -